Typically, fatty liver can be ameliorated by reducing lipid uptake and the suppression of de novo lipid synthesis as well as increased lipid oxidation and enhanced lipid excretion, actions orchestrated by Srebp1c and PPARα [30]. The gene discussed is SREBF1; the disease is fatty liver disease.